Analyze Diet
Methods in molecular biology (Clifton, N.J.)2023; 2749; 175-184; doi: 10.1007/978-1-0716-3609-1_16

Equine Induced Pluripotent Stem Cell Culture.

Abstract: Groundbreaking work by Takahashi and Yamanaka in 2006 demonstrated that non-embryonic cells can be reprogrammed into pluripotent stem cells (PSCs) by forcing the expression of a defined set of transcription factors in culture, thus overcoming ethical concerns linked to embryonic stem cells. Induced PSCs have since revolutionized biomedical research, holding tremendous potential also in other areas such as livestock production and wildlife conservation. iPSCs exhibit broad accessibility, having been derived from a multitude of cell types and species. Apart from humans, iPSCs hold particular medical promise in the horse. The potential of iPSCs has been shown in a variety of biomedical contexts in the horse. However, progress in generating therapeutically useful equine iPSCs has lagged behind that reported in humans, with the generation of footprint-free iPSCs using non-integrative reprogramming approaches having proven particularly challenging. A greater understanding of the underlying molecular pathways and essential factors required for the generation and maintenance of equine iPSCs and their differentiation into relevant lineages will be critical for realizing their significant potential in veterinary regenerative medicine. This article outlines up-to-date protocols for the successful culture of equine iPSC, including colony selection, expansion, and adaptation to feeder-free conditions.
Publication Date: 2023-12-22 PubMed ID: 38133784PubMed Central: 4672244DOI: 10.1007/978-1-0716-3609-1_16Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the protocols and methods to successfully grow and maintain cultures of horse-induced pluripotent stem cells (iPSCs), which can be reprogrammed to regenerate diverse forms of cell types and hold significant potential in veterinary regenerative medicine.

Generation and Relevance of Induced Pluripotent Stem Cells

  • The paper begins by citing the pioneering work by Takahashi and Yamanaka in 2006, which showed the potential of reprogramming non-embryonic cells into pluripotent stem cells (PSCs) by manipulating the expression of a set of transcription factors in culture.
  • Since this discovery, iPSCs have significantly altered the landscape of biomedical research and found applicability in numerous domains such as livestock production and wildlife conservation due to their ability to be derived from a variety of cell types and species.

Challenges and Potential of Equine iPSCs

  • Aside from human cells, horse cells are highlighted as having great medical potential using the iPSC method given the diverse biomedical contexts they’ve been shown to be effective in.
  • However, the authors note that progress in obtaining therapeutically useful equine iPSCs has been slower as compared to human iPSCs.
  • The creation of ‘footprint-free’ iPSCs, which involves non-integrative reprogramming techniques, have been particularly difficult in the horse.

Molecular Understanding and Pathways

  • The paper emphasises that a deeper comprehension of the molecular mechanisms and key factors needed for creation, maintenance and differentiation of equine iPSCs into pertinent lineages will be critical in harnessing their substantial potential in veterinary regenerative medicine.

The Protocol for Equine iPSCs Culture

  • The research provides an update on protocols for the successful culture of equine iPSC, which includes processes such as selecting the right colonies, expansion, and acclimatization to feeder-free conditions. This implies the culture can sustain itself without the need for additional nourishment from feeder cells.

Cite This Article

APA
Falk J, Donadeu FX. (2023). Equine Induced Pluripotent Stem Cell Culture. Methods Mol Biol, 2749, 175-184. https://doi.org/10.1007/978-1-0716-3609-1_16

Publication

ISSN: 1940-6029
NlmUniqueID: 9214969
Country: United States
Language: English
Volume: 2749
Pages: 175-184

Researcher Affiliations

Falk, Julia
  • Division of Translational Bioscience, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK. J.Falk-1@sms.ed.ac.uk.
Donadeu, F Xavier
  • Division of Translational Bioscience, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK.

MeSH Terms

  • Humans
  • Horses
  • Animals
  • Induced Pluripotent Stem Cells
  • Pluripotent Stem Cells
  • Cell Differentiation
  • Embryonic Stem Cells
  • Transcription Factors / metabolism
  • Cellular Reprogramming

References

This article includes 19 references
  1. Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress.. Nat Rev Drug Discov 2017 16(2).
    doi: 10.1038/nrd.2016.245google scholar: lookup
  2. Katayama M, Fukuda T, Kaneko T. Induced pluripotent stem cells of endangered avian species.. Commun Biol 2022 5(1).
  3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.. Cell 2006 126(4).
  4. Steinle H, Weber M, Behring A. Reprogramming of urine-derived renal epithelial cells into iPSCs using srRNA and consecutive differentiation into beating cardiomyocytes.. Mol Ther Nucleic Acids 2019 17.
  5. Donadeu FX, Esteves CL. Prospects and challenges of induced pluripotent stem cells in equine health.. Front Vet Sci 2015 2:59.
    doi: 10.3389/fvets.2015.00059pubmed: 26664986pmc: 4672244google scholar: lookup
  6. Ban H, Nishishita N, Fusaki N. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.. Proc Natl Acad Sci U S A 2011 108(34).
    doi: 10.1073/pnas.1103509108google scholar: lookup
  7. Okita K, Matsumura Y, Sato Y. A more efficient method to generate integration-free human iPS cells.. Nat Methods 2011 8(5).
    doi: 10.1038/nmeth.1591google scholar: lookup
  8. Anokye-Danso F, Trivedi CM, Juhr D. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.. Cell Stem Cell 2011 8(4).
  9. Nagy K, Sung HK, Zhang P. Induced pluripotent stem cell lines derived from equine fibroblasts.. Stem Cell Rev Rep 2011 7(3).
    doi: 10.1007/s12015-011-9239-5google scholar: lookup
  10. Yu L, Wei Y, Sun HX. Derivation of intermediate pluripotent stem cells amenable to primordial germ cell specification.. Cell Stem Cell 2021 28(3).
  11. Chen G, Gulbranson DR, Hou Z. Chemically defined conditions for human iPSC derivation and culture.. Nat Methods 2011 8(5).
    doi: 10.1038/nmeth.1593google scholar: lookup
  12. Wiley LA, Burnight ER, Deluca AP. CGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.. Sci Rep 2016 6.
    doi: 10.1038/srep30742google scholar: lookup
  13. Sharma R, Livesey MR, Wyllie DJA. Generation of functional neurons from feeder-free, keratinocyte-derived equine induced pluripotent stem cells.. Stem Cells Dev 2014 23(13).
    doi: 10.1089/scd.2013.0565google scholar: lookup
  14. Quattrocelli M, Giacomazzi G, Broeckx SY. Equine-induced pluripotent stem cells retain lineage commitment toward myogenic and chondrogenic fates.. Stem Cell Rep 2016 6(1).
  15. Conner DA. Mouse embryo fibroblast (MEF) feeder cell preparation.. Curr Protoc Mol Biol 2001 51:23.
  16. Rodin S, Antonsson L, Hovatta O, Tryggvason K. Monolayer culturing and cloning of human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically defined conditions.. Nat Protoc 2014 9(10).
    doi: 10.1038/nprot.2014.159google scholar: lookup
  17. Braam SR, Zeinstra L, Litjens S. Recombinant Vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via αVβ5 integrin.. Stem Cells 2008 26(9).
  18. Chen G, Gulbranson DR, Hou Z. Chemically defined conditions for human iPSC derivation and culture.. Nat Methods 2011 8(5):424–429.
    doi: 10.1038/nmeth.1593pubmed: 21478862pmc: 3084903google scholar: lookup
  19. Castro-Viñuelas R, Sanjurjo-Rodríguez C, Piñeiro-Ramil M. Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells.. Mol Ther Methods Clin Dev 2021 23.

Citations

This article has been cited 0 times.